We have a team of well-rounded and experienced scientist and pioneers strive to push the boundaries of current scientific research and explore the possibilities of novel therapeutics for cancer and chronic inflammation.
To achieve this goal, Convergen builds its unique database TDLINK. Driven by the database, Convergen team bridges collaboration between scientists, industry professionals, and investors for translation of pioneer sciences.
Convergen team have constructed a pipeline of targeted oncology therapeutics that are diversified by mechanism, therapeutic approach, modality, and stage of development. Welcome to contact our team for collaborations from different perspectives.
Current pipeline of Convergen （dated Aug.5, 2021)